TrialInvestigational new drugs2024
A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy.
Satoshi Hamauchi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.